PEDRO TOMAS RAMIREZ to Radiopharmaceuticals
This is a "connection" page, showing publications PEDRO TOMAS RAMIREZ has written about Radiopharmaceuticals.
Connection Strength
0.229
-
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary. Gynecol Oncol. 2014 Apr; 133(1):100-4.
Score: 0.080
-
Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma. Gynecol Oncol. 2005 Mar; 96(3):888-91.
Score: 0.043
-
Sentinel nodes in gynecologic malignancies. Curr Opin Oncol. 2001 Sep; 13(5):403-7.
Score: 0.034
-
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
Score: 0.029
-
Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
Score: 0.025
-
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
Score: 0.018